Open AccessEfficacy and safety of Tripterygium glycosides in Sjögren’s syndrome treatment: evidence from 12 randomized controlled trials
Author(s) -
Yue Luo,
Ying Zhang,
Le Kuai,
Xing Meng,
Yi Ru,
Ying Luo,
Liu Liu,
Jiale Chen,
Bin Li,
Xin Li
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-256
Subject(s) - medicine , tripterygium , randomized controlled trial , glycoside , traditional medicine , dermatology , stereochemistry , chemistry
Tripterygium glycosides (TGs) has been widely used in the treatment of Sjögren's syndrome (SS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom